Rome V modernizes DGBI diagnosis with refined symptom scales, visual tools, expanded disorders, and pediatric severity assessment, improving precision, consistency, and lifespan care.

Early intervention for severe aortic regurgitation may preserve heart function by treating asymptomatic patients before irreversible ventricular damage develops, emphasizing earlier imaging, referral, and personalized care.

Sirolimus conversion offers selected heart transplant recipients potential long-term benefits, slowing cardiac allograft vasculopathy, preserving kidney function, reducing cancer risk, and improving survival.

A practical overview of COPD dual bronchodilator therapy, comparing LAMA–LABA inhalers by effectiveness, dosing, device usability, cost, patient needs, and environmental impact.

As patients increasingly use AI and social media for health advice, clinicians must address misinformation, delayed care, self-treatment, and digital trust.

Early-onset colorectal cancer is rising among younger adults, with early-life exposures, birth characteristics, and demographics potentially influencing risk and emphasizing earlier diagnostic vigilance.

New real-world evidence suggests semaglutide and tirzepatide may reduce alcohol-related hospitalizations among patients with AUD and metabolic disease, warranting further clinical trials.

FDA’s 2026 regulatory shift on compounded peptides highlights major evidence gaps, manufacturing risks, and safety concerns, requiring clinicians to counsel patients and strengthen monitoring.

Oropouche virus is re-emerging as a global health threat, with expanding transmission, severe neurological and pregnancy complications, diagnostic challenges, and increasing travel-associated cases requiring heightened clinical vigilance.